Clinical trial
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts
NCT03220464 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 20, 2017
- Completion date
- April 30, 2020
- Enrollment
- 116 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.